Advertisement

Topics

GS Capital Partners Company Profile

08:05 EST 13th December 2017 | BioPortfolio

Since 1986, the Goldman Sachs Merchant Banking Division and its predecessor business areas have raised 16 private equity and principal debt investment funds aggregating over $82 billion of capital (including leverage). A global leader in private corporate equity investing, the GS Capital Partners family of funds focuses on large, high quality companies with strong management and funding acquisition or expansion across a range of industries and geographies. Founded in 1869, Goldman Sachs is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals. For more information, please visit www.gs.com/pia


News Articles [1144 Associated News Articles listed on BioPortfolio]

Israeli genetic data co Genoox raises $6m

The round was led by led by Inimiti Capital Partners and Glilot Capital Partners.

MorphoSys-Aktie: Short-Attacke! Leerverkäufer GSA Capital Partners baut Shortposition auf - Aktiennews

Martinsried - Leerverkäufer GSA Capital Partners LLP geht Netto-Leerverkaufsposition in MorphoSys-Aktien ein: Die Leerverkäufer des Hedgefonds GSA Capital Partners LLP attackieren die Aktien des Bi....

Semma's Series B brings in $114mm

Three-year-old regenerative medicine firm Semma Therapeutics Inc. raised $114mm in an oversubscribed Series B financing co-led by Eight Roads Ventures and Cowen Healthcare Investments, which each add ...

M&As this week: Court Square Capital Partners, Quotient Sciences Limited, Jinzi Ham

Court Square Capital Partners has acquired a majority stake in clinical research organisation Celerion Holdings from MTS Health Investors. Both Court...Read More... The post M&As this week: Court...

Paul Capital Partners: Financing and Risk Sharing

In this episode of PharmaTelevision News Review, Fintan Walton talks with Ken MacLeod, Partner at Paul Capital Partners. Filmed at BioTrinity 2010 in Newbury, UK.

Brandon Capital Partners: Dr David Fisher discusses their role in Medical Research Commercialization Fund

In this episode of PharmaTelevision News Review, Fintan Walton talks to Dr David Fisher, Venture Partner of Brandon Capital Partners

Apellis raises $60mm in Series E round

Apellis Pharmaceuticals Inc. (immunotherapies for autoimmune and inflammatory diseases) raised $60mm through its Series E round. Sectoral Asset Management led and was joined by new investors Sofinnova...

Forbion Capital Partners: Geert-Jan Mulder. Optimising commercial potential of portfolio company's products and technologies

In this episode of PharmaTelevision News Review, filmed at BioEurope 2012 in Hamburg, Germany, Fintan Walton talks to Geert-Jan Mulder, General Partner at Forbion Capital Partners

PubMed Articles [350 Associated PubMed Articles listed on BioPortfolio]

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Perceptions of community, social capital, and how they affect self-reported health: a multilevel analysis.

The link between social capital and self-reported health has been widely explored. On the other hand, we know less about the relationship between social capital, community socioeconomic characteristic...

Changes in social capital and depressive states of middle-aged adults in Japan.

The present study examines the relationships between changes in bonding and bridging types of social capital and depressive states among middle-aged adults in Japan using a nationally representative s...

Recovery capital pathways: Modelling the components of recovery wellbeing.

In recent years, there has been recognition that recovery is a journey that involves the growth of recovery capital. Thus, recovery capital has become a commonly used term in addiction treatment and r...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

Clinical Trials [282 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

Companies [1800 Associated Companies listed on BioPortfolio]

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

Thompson Street Capital Partners

Thompson Street Capital Partners has $450 million in capital under management. The private equity firm makes investments in manufacturing, service and distribution businesses. The fund's philosophy is...

Harbinger Capital Partners

Harbinger Capital Partners is a multi-billion dollar private investment fund based in New York which employs a fundamental, intensive research-based approach to investing. ...

Sun Capital Partners, Inc.

Sun Capital Partners, Inc. is a leading private investment firm focused on leveraged buyouts, equity, debt, and other investments in companies that can benefit from its in–ho...

Brandon Capital

Brandon Capital Partners was established in 2007 and makes seed and venture capital investments into emerging businesses in the life science industry. Brandon Capital Partners is ...

More Information about "GS Capital Partners" on BioPortfolio

We have published hundreds of GS Capital Partners news stories on BioPortfolio along with dozens of GS Capital Partners Clinical Trials and PubMed Articles about GS Capital Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GS Capital Partners Companies in our database. You can also find out about relevant GS Capital Partners Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record